title: Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells.
abstract: Based on a mathematical model, we analyze the dynamics of CD4+ cells, actively, latently, persistently, and defectively infected cells and plasma virus after initiation of antiretroviral therapy in 14 HIV-1-infected asymptomatic patients. By simultaneous fitting of our model to clinical data of plasma HIV-1 RNA, peripheral blood mononuclear cell (PBMC)-gag RNA, proviral DNA, and CD4+ cell counts, we estimate kinetic parameters to determine the basic reproductive rate (R0) of the virus in different infected cell compartments as a measure of the replicative capacity of the virus in vivo. We find that the basic reproductive rate is larger than 1 before treatment only in actively infected cells (mean R0(act) approximately 2.46) indicating that only in this compartment the virus can maintain an ongoing infection. In latently and persistently infected cells the basic reproductive rate is considerably smaller (R0(lat) approximately 0.03 and R0(pers) approximately 0.008, respectively) indicating that these compartments contribute little to the total basic reproductive rate and cannot maintain an ongoing infection in absence of actively infected cells.
authors.affiliation: Department of Theoretical and Computational Biology, Friedrich Miescher Institute, Basel, Switzerland.
authors.forename: G A
authors.initials: GA
authors.lastname: Funk
authors.forename: M
authors.initials: M
authors.lastname: Fischer
authors.forename: B
authors.initials: B
authors.lastname: Joos
authors.forename: M
authors.initials: M
authors.lastname: Opravil
authors.forename: H F
authors.initials: HF
authors.lastname: Günthard
authors.forename: B
authors.initials: B
authors.lastname: Ledergerber
authors.forename: S
authors.initials: S
authors.lastname: Bonhoeffer
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D015496:CD4-Positive T-Lymphocytes / Q000821:virology*; D002908:Chronic Disease; D004279:DNA, Viral / Q000097:blood; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D015497:HIV-1 / Q000502:physiology*; D006801:Humans; D008954:Models, Biological; D011533:Proviruses / Q000502:physiology; D012367:RNA, Viral / Q000097:blood; D017735:Virus Latency; D014779:Virus Replication / Q000502:physiology*
chemical_list: D019380:Anti-HIV Agents; D004279:DNA, Viral; D012367:RNA, Viral